Boai Operating Income vs Cost Of Revenue Analysis

300109 Stock

17.75 2.96 20.01%

Boai NKY financial indicator trend analysis is way more than just evaluating Boai NKY Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boai NKY Pharmaceuticals is a good investment. Please check the relationship between Boai NKY Operating Income and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boai NKY Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boai NKY Pharmaceuticals Operating Income account and Cost Of Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Boai NKY's Operating Income and Cost Of Revenue is 0.9. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Boai NKY Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Boai NKY's Operating Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Boai NKY Pharmaceuticals are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Operating Income i.e., Boai NKY's Operating Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Boai NKY Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Boai NKY Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Boai NKY Pharmaceuticals income statement and represents the costs associated with goods and services Boai NKY provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Boai NKY's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boai NKY Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boai NKY Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of December 4, 2024, Selling General Administrative is expected to decline to about 21.8 M. In addition to that, Tax Provision is expected to decline to about 60.6 M

	2021	2022	2023	2024 (projected)
Interest Expense	37.7M	2.6M	2.1M	2.0M
Depreciation And Amortization	181.0M	151.3M	74.2M	44.7M

Interest Expense Depreciation And Amortization

Boai NKY fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.48	0.27	0.74	0.98	0.83	0.66	-0.04	0.88	0.82	0.62	0.97	0.72	0.61	0.6	0.92	0.87	0.92	0.66	0.31	0.77	0.84	0.28	0.92	0.91	0.9
Short Long Term Debt Total	0.48		0.31	0.91	0.32	0.07	-0.01	0.73	0.08	0.02	0.1	0.56	-0.2	-0.16	0.08	0.55	0.38	0.18	-0.11	0.52	0.9	0.3	0.81	0.17	0.47	0.17
Other Current Liab	0.27	0.31		0.49	0.19	0.13	-0.25	0.14	0.17	0.23	0.17	0.28	0.23	0.18	0.14	0.35	0.38	0.21	0.14	0.37	0.48	0.27	0.27	0.29	0.37	0.26
Total Current Liabilities	0.74	0.91	0.49		0.6	0.38	0.23	0.47	0.42	0.38	0.37	0.76	0.18	0.12	0.35	0.77	0.64	0.5	0.18	0.51	1.0	0.59	0.66	0.5	0.72	0.49
Total Stockholder Equity	0.98	0.32	0.19	0.6		0.88	0.71	-0.19	0.93	0.87	0.63	0.94	0.8	0.69	0.62	0.87	0.87	0.95	0.73	0.23	0.64	0.84	0.15	0.96	0.88	0.94
Property Plant And Equipment Net	0.83	0.07	0.13	0.38	0.88		0.62	-0.24	0.98	0.95	0.42	0.82	0.87	0.88	0.41	0.6	0.69	0.97	0.91	-0.21	0.41	0.6	-0.09	0.9	0.67	0.97
Current Deferred Revenue	0.66	-0.01	-0.25	0.23	0.71	0.62		-0.54	0.72	0.63	0.77	0.52	0.67	0.37	0.79	0.57	0.52	0.68	0.49	0.09	0.28	0.76	-0.18	0.66	0.56	0.63
Net Debt	-0.04	0.73	0.14	0.47	-0.19	-0.24	-0.54		-0.33	-0.36	-0.61	0.15	-0.58	-0.24	-0.63	0.0	-0.18	-0.24	-0.28	0.06	0.44	-0.38	0.65	-0.33	-0.09	-0.25
Retained Earnings	0.88	0.08	0.17	0.42	0.93	0.98	0.72	-0.33		0.97	0.56	0.83	0.92	0.86	0.55	0.69	0.74	0.99	0.88	-0.09	0.45	0.72	-0.12	0.94	0.72	0.97
Accounts Payable	0.82	0.02	0.23	0.38	0.87	0.95	0.63	-0.36	0.97		0.53	0.77	0.93	0.85	0.53	0.64	0.72	0.96	0.85	-0.11	0.4	0.69	-0.21	0.92	0.67	0.95
Cash	0.62	0.1	0.17	0.37	0.63	0.42	0.77	-0.61	0.56	0.53		0.42	0.6	0.15	1.0	0.64	0.69	0.54	0.26	0.52	0.4	0.91	-0.01	0.67	0.68	0.55
Non Current Assets Total	0.97	0.56	0.28	0.76	0.94	0.82	0.52	0.15	0.83	0.77	0.42		0.62	0.64	0.41	0.87	0.81	0.88	0.67	0.23	0.79	0.71	0.37	0.86	0.85	0.87
Non Currrent Assets Other	0.72	-0.2	0.23	0.18	0.8	0.87	0.67	-0.58	0.92	0.93	0.6	0.62		0.86	0.6	0.58	0.65	0.89	0.81	-0.09	0.22	0.69	-0.4	0.86	0.6	0.88
Other Assets	0.61	-0.16	0.18	0.12	0.69	0.88	0.37	-0.24	0.86	0.85	0.15	0.64	0.86		0.14	0.41	0.47	0.84	0.88	-0.38	0.15	0.35	-0.32	0.72	0.42	0.82
Cash And Short Term Investments	0.6	0.08	0.14	0.35	0.62	0.41	0.79	-0.63	0.55	0.53	1.0	0.41	0.6	0.14		0.63	0.68	0.54	0.25	0.51	0.38	0.91	-0.04	0.66	0.67	0.54
Net Receivables	0.92	0.55	0.35	0.77	0.87	0.6	0.57	0.0	0.69	0.64	0.64	0.87	0.58	0.41	0.63		0.88	0.74	0.41	0.57	0.81	0.89	0.31	0.78	0.95	0.72
Common Stock Shares Outstanding	0.87	0.38	0.38	0.64	0.87	0.69	0.52	-0.18	0.74	0.72	0.69	0.81	0.65	0.47	0.68	0.88		0.78	0.54	0.47	0.67	0.88	0.26	0.87	0.97	0.82
Inventory	0.92	0.18	0.21	0.5	0.95	0.97	0.68	-0.24	0.99	0.96	0.54	0.88	0.89	0.84	0.54	0.74	0.78		0.84	-0.03	0.53	0.74	-0.05	0.94	0.77	0.99
Other Current Assets	0.66	-0.11	0.14	0.18	0.73	0.91	0.49	-0.28	0.88	0.85	0.26	0.67	0.81	0.88	0.25	0.41	0.54	0.84		-0.36	0.2	0.41	-0.15	0.78	0.48	0.85
Other Stockholder Equity	0.31	0.52	0.37	0.51	0.23	-0.21	0.09	0.06	-0.09	-0.11	0.52	0.23	-0.09	-0.38	0.51	0.57	0.47	-0.03	-0.36		0.53	0.54	0.51	0.18	0.52	0.0
Total Liab	0.77	0.9	0.48	1.0	0.64	0.41	0.28	0.44	0.45	0.4	0.4	0.79	0.22	0.15	0.38	0.81	0.67	0.53	0.2	0.53		0.63	0.64	0.53	0.76	0.52
Total Current Assets	0.84	0.3	0.27	0.59	0.84	0.6	0.76	-0.38	0.72	0.69	0.91	0.71	0.69	0.35	0.91	0.89	0.88	0.74	0.41	0.54	0.63		0.12	0.82	0.9	0.73
Short Term Debt	0.28	0.81	0.27	0.66	0.15	-0.09	-0.18	0.65	-0.12	-0.21	-0.01	0.37	-0.4	-0.32	-0.04	0.31	0.26	-0.05	-0.15	0.51	0.64	0.12		0.08	0.34	0.0
Intangible Assets	0.92	0.17	0.29	0.5	0.96	0.9	0.66	-0.33	0.94	0.92	0.67	0.86	0.86	0.72	0.66	0.78	0.87	0.94	0.78	0.18	0.53	0.82	0.08		0.84	0.95
Common Stock	0.91	0.47	0.37	0.72	0.88	0.67	0.56	-0.09	0.72	0.67	0.68	0.85	0.6	0.42	0.67	0.95	0.97	0.77	0.48	0.52	0.76	0.9	0.34	0.84		0.8
Property Plant Equipment	0.9	0.17	0.26	0.49	0.94	0.97	0.63	-0.25	0.97	0.95	0.55	0.87	0.88	0.82	0.54	0.72	0.82	0.99	0.85	0.0	0.52	0.73	0.0	0.95	0.8

Click cells to compare fundamentals

Boai NKY Account Relationship Matchups

Boai NKY fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.2B	4.1B	4.0B	3.7B	4.0B	4.2B
Short Long Term Debt Total	937.8M	767.2M	99.0M	72.6M	60.4M	57.4M
Other Current Liab	13.0M	90.9M	1.6M	238.6M	2.2M	2.1M
Total Current Liabilities	976.7M	1.0B	501.6M	502.0M	426.9M	356.3M
Total Stockholder Equity	3.0B	3.1B	3.4B	3.1B	3.5B	3.7B
Property Plant And Equipment Net	569.6M	611.0M	731.2M	844.8M	1.3B	1.4B
Current Deferred Revenue	106.5M	19.0M	267.0M	29.3M	136.9M	143.7M
Net Debt	652.6M	535.6M	(1.1B)	(472.3M)	(230.4M)	(218.8M)
Retained Earnings	412.3M	446.1M	724.0M	732.3M	1.0B	1.1B
Accounts Payable	46.9M	156.4M	188.3M	211.2M	260.1M	273.1M
Cash	285.2M	231.6M	1.2B	544.9M	290.8M	259.9M
Non Current Assets Total	3.1B	3.1B	1.8B	2.3B	2.8B	3.0B
Non Currrent Assets Other	52.1M	115.1M	640.2M	832.1M	723.7M	759.8M
Other Assets	1.0	148.6M	102.8M	883.3M	1.0B	1.1B
Cash And Short Term Investments	285.2M	276.7M	1.4B	576.9M	325.0M	280.2M
Net Receivables	649.2M	611.5M	573.7M	565.9M	475.1M	239.4M
Common Stock Shares Outstanding	272.9M	323.1M	333.9M	342.9M	324.4M	217.8M
Liabilities And Stockholders Equity	4.2B	4.1B	4.0B	3.7B	4.0B	4.2B
Inventory	183.8M	185.8M	230.4M	247.0M	309.8M	325.3M
Other Current Assets	12.2M	17.0M	22.1M	43.5M	77.2M	81.0M
Total Liab	1.1B	1.1B	589.8M	596.3M	499.7M	395.5M
Total Current Assets	1.1B	1.1B	2.2B	1.4B	1.2B	661.0M
Short Term Debt	810.4M	734.9M	44.8M	22.9M	27.8M	26.4M
Intangible Assets	79.6M	126.0M	145.7M	149.3M	148.1M	155.5M
Property Plant Equipment	569.6M	611.0M	731.2M	844.8M	971.5M	1.0B
Other Liab	31.9M	32.4M	33.9M	44.5M	51.2M	53.8M
Non Current Liabilities Total	167.4M	68.0M	88.1M	94.3M	72.7M	44.4M
Short Term Investments	(68.4M)	45.0M	201.7M	32.0M	34.2M	30.1M
Good Will	442.1M	2.2B	2.1B	341.7M	392.9M	373.3M
Net Tangible Assets	820.3M	846.2M	3.0B	2.7B	3.1B	3.2B
Long Term Debt	135.8M	32.3M	54.2M	48.9M	32.6M	45.7M
Deferred Long Term Liab	17.8M	19.9M	39.3M	41.2M	47.4M	49.8M
Net Invested Capital	4.0B	3.8B	3.5B	3.2B	3.6B	3.4B
Short Long Term Debt	801.1M	655.0M	39.4M	16.7M	15.0M	14.2M
Net Working Capital	153.6M	89.6M	1.7B	931.3M	760.1M	519.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Boai Stock

Balance Sheet is a snapshot of the financial position of Boai NKY Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Boai NKY Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Boai NKY and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Boai currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boai Operating Income vs Cost Of Revenue Analysis

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Operating Income

Cost Of Revenue

Boai NKY fundamental ratios Correlations

Boai NKY Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boai NKY fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Boai Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Inventory	+ 0.99	Retained Earnings
Property Plant Equipment	+ 0.99	Inventory
Total Stockholder Equity	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Property Plant And Equipment Net

Cash And Short Term Investments	- 0.63	Net Debt
Cash	- 0.61	Net Debt
Non Currrent Assets Other	- 0.58	Net Debt
Net Debt	- 0.54	Current Deferred Revenue
Short Term Debt	- 0.4	Non Currrent Assets Other
Other Stockholder Equity	- 0.38	Other Assets